BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33879034)

  • 1. Association of negative symptoms with cognitive impairment in Chinese Han patients with chronic schizophrenia.
    Zhu R; Wang D; Wei G; Wang J; Zhou H; Xu H; Wang W; Wei S; Chen D; Xiu M; Wang L; Zhang XY
    Int J Psychiatry Clin Pract; 2021 Sep; 25(3):292-298. PubMed ID: 33879034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in the association of body mass index with symptoms and cognitive deficits in Chinese patients with chronic schizophrenia.
    Wei CW; Chen YQ; Ma M; Xiu MH; Zhang XY
    Transl Psychiatry; 2020 Jan; 10(1):18. PubMed ID: 32066717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive dyskinesia is associated with greater cognitive impairment in schizophrenia.
    Wu JQ; Chen DC; Xiu MH; Tan YL; Yang FD; Kosten TR; Zhang XY
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():71-7. PubMed ID: 23827756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cigarette smoking and cognitive function in Chinese male schizophrenia: a case-control study.
    Zhang XY; Chen DC; Xiu MH; Haile CN; Sun H; Lu L; Kosten TA; Kosten TR
    PLoS One; 2012; 7(5):e36563. PubMed ID: 22570726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Clinical Correlates of and Cognitive Function at the Time of Suicide Attempts in First-Episode and Drug-Naive Patients With Schizophrenia.
    Zhang XY; Du X; Yin G; Zhang Y; Chen D; Xiu M; Wang C; Zhang R; Cassidy RM; Ning Y; Huang X; Soares JC
    J Clin Psychiatry; 2018 Jul; 79(4):. PubMed ID: 30063302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex difference in association between tardive dyskinesia and cognitive deficits in patients with chronic schizophrenia.
    Zhang W; Wang D; Zhou H; Chen D; Xiu M; Cui L; Zhang X
    Schizophr Res; 2023 May; 255():140-147. PubMed ID: 36989671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex difference in association between insomnia and cognitive impairment in patients with chronic schizophrenia.
    Zhu R; Wang D; Tian Y; Du Y; Chen J; Zhou H; Chen D; Wang L; Alonzo BA; Emily Wu H; Yang Zhang X
    Schizophr Res; 2022 Feb; 240():143-149. PubMed ID: 35026599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 18 and cognitive impairment in first episode and drug naïve schizophrenia versus healthy controls.
    Zhang XY; Tang W; Xiu MH; Chen DC; Yang FD; Tan YL; Wang ZR; Zhang F; Liu J; Liu L; Chen Y; Wen N; Kosten TR
    Brain Behav Immun; 2013 Aug; 32():105-11. PubMed ID: 23499732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of depressive symptoms with cognitive impairment in patients with never-treated first-episode schizophrenia: Analysis of the Depression in Schizophrenia in China (DISC) study.
    Chen XJ; Wang DM; Zhou HX; Zhu RR; Tian Y; Du YX; Chen JJ; Chen DC; Wang L; Zhang XY
    Gen Hosp Psychiatry; 2021; 71():108-113. PubMed ID: 34000518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairments in first-episode drug-naive and chronic medicated schizophrenia: MATRICS consensus cognitive battery in a Chinese Han population.
    Wu JQ; Chen DC; Tan YL; Xiu MH; De Yang F; Soares JC; Zhang XY
    Psychiatry Res; 2016 Apr; 238():196-202. PubMed ID: 27086233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients.
    Zhang XY; Chen DC; Xiu MH; Yang FD; Haile CN; Kosten TA; Kosten TR
    J Clin Psychiatry; 2012 Jul; 73(7):1025-33. PubMed ID: 22901352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of cognitive and P50 suppression deficits in chronic patients with schizophrenia.
    Xia L; Wang D; Wang J; Xu H; Huo L; Tian Y; Dai Q; Wei S; Wang W; Zhang G; Du X; Jia Q; Zhu X; Wang L; Tang W; Zhang XY
    Clin Neurophysiol; 2020 Mar; 131(3):725-733. PubMed ID: 32000073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical symptoms and cognitive impairment associated with male schizophrenia relate to plasma manganese superoxide dismutase activity: a case-control study.
    Zhang XY; Chen DC; Xiu MH; Tan YL; Yang FD; Zhang LY; Zhang LY; Haile CN; Kosten TR
    J Psychiatr Res; 2013 Aug; 47(8):1049-53. PubMed ID: 23611682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin, a novel oxidative stress marker and cognitive performance in chronic and medicated schizophrenia versus healthy controls.
    Zhang XY; Chen DC; Xiu MH; Yang FD; Tan YL; He S; Kosten TA; Kosten TR
    Schizophr Res; 2013 Feb; 143(2-3):301-6. PubMed ID: 23238053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age of Onset Moderates the Association between Total Antioxidant Capacity and Cognitive Deficits in Patients with Drug-Naïve Schizophrenia.
    Li J; Li D; Guo J; Wang D; Zhang X
    Antioxidants (Basel); 2023 Jun; 12(6):. PubMed ID: 37371989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCF4 gene polymorphism is associated with cognition in patients with schizophrenia and healthy controls.
    Hui L; Rao WW; Yu Q; Kou C; Wu JQ; He JC; Ye MJ; Liu JH; Xu XJ; Zheng K; Ruan LN; Liu HY; Hu WM; Shao TN; AngRabanes MB; Soares JC; Zhang XY
    J Psychiatr Res; 2015 Oct; 69():95-101. PubMed ID: 26343600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P50 inhibition defects with psychopathology and cognitive impairment in patients with first-episode drug naïve schizophrenia.
    Xia L; Wang D; Wei G; Wang J; Zhou H; Xu H; Tian Y; Dai Q; Xiu M; Chen D; Wang L; Zhang X
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Apr; 107():110246. PubMed ID: 33453321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits.
    Chen DC; Du XD; Yin GZ; Yang KB; Nie Y; Wang N; Li YL; Xiu MH; He SC; Yang FD; Cho RY; Kosten TR; Soares JC; Zhao JP; Zhang XY
    Psychol Med; 2016 Nov; 46(15):3219-3230. PubMed ID: 27604840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma total antioxidant status and cognitive impairments in schizophrenia.
    Zhang XY; Chen DC; Xiu MH; Tang W; Zhang F; Liu L; Chen Y; Liu J; Yao JK; Kosten TA; Kosten TR
    Schizophr Res; 2012 Aug; 139(1-3):66-72. PubMed ID: 22555016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between cognitive impairment and superoxide dismutase activity in untreated first-episode patients with schizophrenia.
    Wang DM; Du YX; Zhu RR; Tian Y; Chen JJ; Chen DC; Wang L; Zhang XY
    World J Biol Psychiatry; 2022 Sep; 23(7):517-524. PubMed ID: 34918615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.